CRISPR/Cas9 technology generated a G to A change resulting in a methionine to isoleucine substitution at residue 120 (M120I) in exon 4. In addition, a C to T change was introduced to modify the upstream Pstl site. M120I is an autism spectrum disorder-linked mutation found in humans. (J:310040)